|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismATXN3 gene modulators |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismDMD exon 53 modulators |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Asocura Pharmaceuticals Suzhou Co., Ltd.
0 Patents (Medical) associated with Asocura Pharmaceuticals Suzhou Co., Ltd.
100 Deals associated with Asocura Pharmaceuticals Suzhou Co., Ltd.
100 Translational Medicine associated with Asocura Pharmaceuticals Suzhou Co., Ltd.